Treace Medical Concepts, Inc. (NASDAQ:TMCI) has 111 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 6,364,000 | 0 | 0.00% | $8,527,760.00 |
| GAGNON SECURITIES LLC | 31 Mar, 2026 | 5,201,886 | 2,091,311 | 67.23% | $6,970,527.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,340,023 | -71,115 | -2.08% | $4,475,632.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 3,214,293 | 900,071 | 38.89% | $4,307,153.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,461,507 | 1,461,507 | 0.00% | $1,958,419.00 |
| State Street Corp | 31 Mar, 2026 | 1,235,518 | 241,327 | 24.27% | $1,655,594.00 |
| CIBC Bancorp USA Inc. | 31 Mar, 2026 | 1,218,353 | 1,218,353 | 0.00% | $1,632,593.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,148,115 | -354,796 | -23.61% | $1,538,474.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,061,840 | 1,061,840 | 0.00% | $1,422,866.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,010,843 | -133,529 | -11.67% | $1,354,788.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 941,293 | 278,508 | 42.02% | $1,255.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 841,269 | 211,139 | 33.51% | $1,127,300.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 825,575 | 613,669 | 289.59% | $1,106,270.00 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 31 Mar, 2026 | 589,617 | 0 | 0.00% | $790,087.00 |
| UBS Group AG | 31 Mar, 2026 | 542,905 | 248,976 | 84.71% | $727,493.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 522,900 | 522,900 | 0.00% | $700,686.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 435,893 | 435,893 | 0.00% | $584,097.00 |
| Northern Trust Corp | 31 Mar, 2026 | 405,903 | 12,138 | 3.08% | $543,910.00 |
| GSA CAPITAL PARTNERS LLP | 31 Mar, 2026 | 398,007 | 50,252 | 14.45% | $533.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 387,685 | 9,981 | 2.64% | $519,498.00 |